1 hour ago
Eli Lilly (LLY) Eyes $2 Billion+ Acquisition of Cancer Therapy Startup Kelonia
Eli Lilly (LLY) stock gained 2.55% amid reports the company is finalizing a $2B+ acquisition of CAR-T cancer biotech Kelonia Therapeutics.
The post Eli Lilly (LLY) Eyes $2 Billion+ Acquisition of Cancer Therapy Startup Kelonia appeared first on Blockonomi.
Source: Blockonomi →Related News
- 44 minutes ago
American Express (AXP) Stock: Should You Buy Before or After Q1 Earnings?
- 45 minutes ago
Archer Aviation (ACHR) Stock Rallies 24% as Bullish Catalysts Emerge
- 1 hour ago
ARK Invest Snaps Up Netflix (NFLX) After Earnings Drop While Dumping Crypto Hold...
- 1 hour ago
Amazon (AMZN) Gets $300 Price Target From Morgan Stanley Following $11.6B Global...
- 1 hour ago
Should You Buy Tesla (TSLA) Stock Ahead of Q1 2026 Earnings Report?